Chemomab Therapeutics Statistics
NASDAQ: CMMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.40+0.01 (+0.72%)
Market open · Delayed 15 min · as of Oct 9, 1:20 PM ET
Chemomab Therapeutics by the numbers
Chemomab Therapeutics has a market capitalization of $10.3 million based on 7.33M shares outstanding. With trailing EPS of $-1.04, Chemomab Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.7% below its 50-day average and 22.4% below its 200-day average.
Average daily trading volume is 113.36K shares, or about $158,711 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CMMB valuation vs. peer median
| Metric | CMMB | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.26M | $10.33M | -1% |
| Avg. volume | 113.36K | 377.22K | -70% |
Peer median across 8 companies: TOVX, ENSC, ADIL, VTGN, GDTC, JAGX, GTBP, MTVA.
Valuation
- Market cap
- $10.26M
- EPS (TTM)
- $-1.04
- Shares outstanding
- 7.33M
Price and trading
- Previous close
- 1.39
- Open
- 1.38
- Day range
- 1.38 – 1.47
- 52-week range
- 1.05 – 3.50
- 52-week change
- -60.29%
- Beta
- —
- Volume
- 4.28K
- Average volume
- 113.36K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 8, 2026
Additional statistics
- Market Cap
- 10.26M
- Forward Pe
- -46.67
- Eps
- -1.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.50
- Week52 Low
- 1.05
- Avg Volume
- 113.36K
- Shares Outstanding
- 7.33M
- Ma50
- 2.11
- Ma200
- 1.80
- Earnings Date
- Oct 8, 2026
- Pct From52w High
- -60.00%
- Pct From52w Low
- 33.21%